PatoGen Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

PatoGen General Information

Description

Provider of laboratory and biotechnology research services dedicated to the detection of fish pathogens. The company develops and sells genetic engineering analyzers for the aquaculture industry to prevent infection and disease for its customers in Norway and Scotland, thereby offering expertise and quality data to generate sustainable growth of seafood production.

Contact Information

Website
www.patogen.no
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Rasmus Rønnebergs Gate 21
  • 6002 Ålesund
  • Norway
+47 70
Primary Industry
Other Commercial Services
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Fürst Medisinsk Laboratorium
Vertical(s)
Life Sciences
Corporate Office
  • Rasmus Rønnebergs Gate 21
  • 6002 Ålesund
  • Norway
+47 70

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PatoGen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PatoGen‘s full profile, request access.

Request a free trial

PatoGen Patents

  • 28

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

PatoGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3185583-A1 Piscine orthoreovirus virulence markers Pending 14-Jul-2020
EP-4182483-A1 Piscine orthoreovirus virulence markers Inactive 14-Jul-2020
CA-3162676-A1 Method for detecting hydrogen peroxide resistance in crustaceans Inactive 02-Jan-2020
EP-4085155-A1 Method for detecting hydrogen peroxide resistance in crustaceans Inactive 02-Jan-2020
EP-3918095-A1 Piscine orthoreovirus virulence markers Pending 30-Jan-2019 C12Q1/701
To view PatoGen’s complete patent history, request access »

PatoGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PatoGen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PatoGen‘s full profile, request access.

Request a free trial

PatoGen Subsidiaries (1)

Company Name Industry Location Founded
Patogen Nord Other Commercial Services Bodoe, Norway
To view PatoGen’s complete subsidiaries history, request access »

PatoGen FAQs

  • When was PatoGen founded?

    PatoGen was founded in 2005.

  • Where is PatoGen headquartered?

    PatoGen is headquartered in Ålesund, Norway.

  • What is the size of PatoGen?

    PatoGen has 60 total employees.

  • What industry is PatoGen in?

    PatoGen’s primary industry is Other Commercial Services.

  • Is PatoGen a private or public company?

    PatoGen is a Private company.

  • What is PatoGen’s current revenue?

    The current revenue for PatoGen is .

  • Who are PatoGen’s investors?

    Kverva has invested in PatoGen.

  • When was PatoGen acquired?

    PatoGen was acquired on 04-Aug-2021.

  • Who acquired PatoGen?

    PatoGen was acquired by Fürst Medisinsk Laboratorium.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »